| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.085 | 0.07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.088 | 0.07 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.088 | 0.09 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.065 | 0.2 |